# Patient Care Plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Franklin D. Roosevelt (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET002-SYN
- Date: 2026-03-27
- Fictional facility: St. Posthumous Health Center
- Fictional author: Nathaniel Brooks, MD
- Calendar frame: modern shifted

## What we are working on

- Breathlessness, poor sleep from orthopnea, and leg swelling are cutting short his workdays **S**
- Wants to stop smoking without losing his edge at work **S**

## Your goals

- Lower blood pressure below 130/80 by the six-month review. Target: 2026-09-25. Recorded outcome: Blood pressure 122/76. **S**
- Improve the KCCQ-12 overall summary score by at least 20 points by the three-month review. Target: 2026-06-26. Recorded outcome: KCCQ-12 rose from 38 to 64. **S**
- Stop smoking by the three-month review. Target: 2026-06-26. Recorded outcome: No cigarettes since April; nicotine patch course completed. **S**
- Reach the highest tolerated doses of guideline-directed therapy by the six-month review. Target: 2026-09-25. Recorded outcome: Sacubitril/valsartan 49/51 mg twice daily, carvedilol 12.5 mg twice daily, spironolactone, and empagliflozin. **S**

## What we agreed to do

- Start guideline-directed therapy for HFrEF: sacubitril/valsartan, carvedilol, and empagliflozin, with furosemide for congestion; add spironolactone after the two-week potassium check. Guideline: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (2022) **S**
- Check a basic metabolic panel one to two weeks after each renin-angiotensin or mineralocorticoid antagonist change, then every three to six months when stable. Guideline: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (2022); CMID: Clinical Monitoring Intelligence Database, heart failure and hypertension monographs (2026) **S**
- Treat to a blood pressure below 130/80 with home blood pressure and daily weight logs; low-sodium diet. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2025); CMID: Clinical Monitoring Intelligence Database, heart failure and hypertension monographs (2026) **S**
- Give intravenous ferric carboxymaltose for iron deficiency with ferritin below 100 ng/mL and transferrin saturation below 20%. Guideline: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (2022) **S**
- Tobacco cessation counseling with nicotine replacement and a quit date. Guideline: Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021) **S**
- Cardiology referral to confirm the diagnosis, review the echocardiogram, and guide titration. Guideline: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (2022) **S**
- Repeat echocardiogram three to six months after reaching tolerated doses to decide on device therapy. Guideline: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (2022); CMID: Clinical Monitoring Intelligence Database, heart failure and hypertension monographs (2026) **S**

## Follow-up

- 2026-03-27: Primary care visit for breathlessness, orthopnea, and leg swelling **S**
- 2026-04-10: Two-week heart failure medication safety check and echocardiogram **S**
- 2026-06-26: Three-month heart failure and blood pressure review **S**
- 2026-09-25: Six-month heart failure review with repeat echocardiogram **S**
- 2026-10-23: Periodic adult preventive visit **S**

This teaching document does not replace care from a qualified clinician.
